Blog

SMART breakthrough offers a promising pathway toward improved manufacturing of high-quality cells for regenerative therapies to treat joint diseases.

“What we found in our study when we used osteochondral allografts, which have bone and cartilage, is that the addition of a tibial tubercle osteotomy did not improve the outcomes in these patients and, many times, there were more complications associated with healing issues with the tibial tubercl...

Biopsy confirmed a diagnosis of osteosarcoma, while staging scans showed no evidence of metastatic disease.

Transcatheter deep venous arterialization was tied to high rates of limb salvage and wound healing in patients with “no option” chronic limb-threatening ischemia

When a patient is diagnosed with osteosarcoma, an aggressive form of bone cancer, the mission is to remove the tumor entirely. Leaving behind even a microscopic cluster of malignant cells can be the difference between remission and cancer recurrence.

Detecting whether osteosarcoma, a rare but aggressive bone cancer that most often affects children and adolescents, has returned or spread remains a major challenge for patients and doctors.

A single infusion of ciltacabtagene autoleucel (Carvykti) led to a 100% minimal residual disease (MRD)-negativity rate in patients with high-risk smoldering multiple myeloma,

Soft tissue sarcomas are a rare and often hard-to-treat group of cancers that typically require a combination of surgery, radiation therapy and other systemic treatments.

Long-term adverse events were rare and manageable among patients with alveolar soft part sarcoma (ASPS), which primarily affects adolescents and young adults

Adherence was generally high among participants with available data, though limited by underreporting. Hip-related quality of life (iHOT-33) improved despite limited changes in physical impairments, and no improvement in functional performance.